Molecular Partners to present at inaugural UBS Global Biopharma Conference

MOLN•2026-11-13

Molecular Partners will present at the inaugural UBS Global Biopharma Conference in London on Nov. 16-17, 2026. CEO Patrick Amstutz will outline business developments and outlook on Nov. 17 at 8 a.m. GMT.

1. Conference presentation

Molecular Partners will present at the inaugural UBS Global Biopharma Conference in London on Nov. 16-17, 2026. CEO Patrick Amstutz is scheduled to outline business developments and outlook on Nov. 17 at 8 a.m. GMT (9 a.m. CET) at the Rosewood Hotel.

Molecular Partners to present at inaugural UBS Global Biopharma Conference

1. Conference presentation

Related News

Goldman Sachs flags risks to $15,400/t copper price forecast for 2027

Keurig Dr Pepper raises $2 billion stock offering to cut debt ahead of split

Willamette Valley Vineyards declares annual dividend of $0.22 per Series A preferred share

Lancashire Holdings: Peel Hunt raises target price to 670p from 640p

Gold rises on bargain hunting but heads for weekly decline